|
|
|
Sunday, March 21, 2010 — 1:30 PM, Virginia
|
- Prognostic and Diagnostic Challenges in Head & Neck Pathology
|
|
Moderator:
|
Prognostic and Diagnostic Challenges in Head & Neck Pathology
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 1:30 | Prognostic Indicators in Head and Neck Oncology Including Changes in the New AJCC 7th Edition - Margaret Brandwein-Gensler, Albert Einstein College of Medicine, Bronx, NY |
| 2:00 | Integration of Biomarkers, Including Molecular Targeted Therapies in Head and Neck Cancer - Michelle D. Williams, UT MD Anderson Cancer Center, Houston, TX |
| 2:30 | The Small Blue Round Cell Tumors of the Sinonasal Area - Julia A. Bridge, University of Nebraska Medical Center, Omaha, NE |
| 3:00 | Break |
| 3:30 | Selected Soft Tissue Lesions of the Head and Neck - Andrew Folpe, Mayo Clinic, Rochester, MN |
| 4:00 | Selected Non-Mucosal Lesions of the Sinonasal Area - Ilan Weinreb, University Health Network, Toronto, ON, Canada |
| 4:30 | Selected Cutaneous Lesions of the Head and Neck - Daniel Santa Cruz, Cutaneous Pathology WCP Laboratories, Maryland Heights, MO |
The NASHNP solicited topics of interest from current and previous officers as well as select members of the NASHNP. Several potential topics were discussed and topics selected were chosen in agreement with the chair of the scientific program committee. Improving diagnoses of head and neck cancers, updates on emerging critical therapeutic/diagnostic issues, as well as reporting of cancers were of high interest to NASHNP membership as well as the larger pathology community and are the goals of this symposium. The NASHNP membership is focused on the dissemination of best practices to reduce interpretation errors and to improve quality and reporting of diagnoses.
Our needs assessment process was based on evaluation of current literature, the recent publication of the AJCC Cancer Staging Handbook 7th edition and consultation with selected members and officers of our Society.
The NASHNP is ver excited about the 2010 program, one that we are confident is in keeping with the quality expected of Companion Societies, and one that we feel will appeal to a broad spectrum of pathologists in all practice settings. We will evaluate effectiveness by monitoring attendance and tracking the scope and breadth of questions and the evaluations of each speaker.
|
|
|
|
